You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 10, October 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision

D. T. Tan, S. P. Chee, K. B. Dear and A. S. Lim
Singapore National Eye Centre, Singapore.

OBJECTIVES: To compare success rates of conjunctival autografting and bare sclera excision for primary and recurrent pterygium in the tropics and to evaluate risk factors for pterygium recurrence. METHODS: A prospective, controlled clinical trial was performed in which 123 primary and 34 recurrent pterygia, matched for age and pterygium morphology, were randomized in 2 separate studies to receive either bare sclera excision or conjunctival autograft. The surgical procedures were performed by one surgeon and reviewed at 1, 3, 6, and 12 months after surgery by an independent observer. Pterygium morphology was clinically graded as atrophic, intermediate, or fleshy according to an assessment of pterygium translucency. Risk factors were assessed using likelihood ratio tests. Weibull curves were used to estimate recurrence rates allowing for the interval censoring. RESULTS: In the group with primary pterygium (mean follow-up, 15.1 months), 38 (61%) of the 62 cases of bare sclera excision (heretofore referred to as the bare sclera group) had pterygium recur in contrast with 1 (2%) of the 61 cases of conjunctival autograft (heretofore referred to as the conjunctival autograph group) (P<.001, likelihood ratio X2 test). Nontranslucency, or fleshiness of the pterygium, and not age was a significant risk factor for recurrence in the bare sclera group (P<.001, likelihood ratio X2 test). In the group with recurrent pterygium (mean follow-up, 13.2 months), 14 (82%) of the 17 bare sclera group had pterygium recur, while no recurrences occurred among 17 cases in the conjunctival autograft group. Nontranslucency was again a highly significant factor for recurrence (P<.001, likelihood ratio X2 test). CONCLUSIONS: Pterygium recurrence is related to pterygium morphology and fleshiness of the pterygium is a significant risk factor for recurrence if bare sclera excision is performed. Conjunctival autografting for primary and recurrent pterygium is effective in reducing pterygium recurrence compared with bare sclera excision.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study
Karalezli et al.
Br. J. Ophthalmol. 2008;92:1206-1210.
ABSTRACT | FULL TEXT  

The prevalence, severity and risk factors for pterygium in central Myanmar: the Meiktila Eye Study
Durkin et al.
Br. J. Ophthalmol. 2008;92:25-29.
ABSTRACT | FULL TEXT  

Modulation of Cholesterol Homeostasis by Antiproliferative Drugs in Human Pterygium Fibroblasts
Peiretti et al.
IOVS 2007;48:3450-3458.
ABSTRACT | FULL TEXT  

Novel Sutureless Transplantation of Bioadhesive-Coated, Freeze-Dried Amniotic Membrane for Ocular Surface Reconstruction
Sekiyama et al.
IOVS 2007;48:1528-1534.
ABSTRACT | FULL TEXT  

Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision
Luanratanakorn et al.
Br. J. Ophthalmol. 2006;90:1476-1480.
ABSTRACT | FULL TEXT  

UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling.
Di Girolamo et al.
IOVS 2006;47:2430-2437.
ABSTRACT | FULL TEXT  

Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia
Touhami et al.
Br. J. Ophthalmol. 2005;89:269-274.
ABSTRACT | FULL TEXT  

Hyperexpression of Low-Density Lipoprotein Receptors and Hydroxy-Methylglutaryl-Coenzyme A-Reductase in Human Pinguecula and Primary Pterygium
Peiretti et al.
IOVS 2004;45:3982-3985.
ABSTRACT | FULL TEXT  

Cut and paste: a no suture, small incision approach to pterygium surgery
Koranyi et al.
Br. J. Ophthalmol. 2004;88:911-914.
ABSTRACT | FULL TEXT  

Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body Fibroblasts
Solomon et al.
IOVS 2003;44:573-580.
ABSTRACT | FULL TEXT  

Pterygium in Indonesia: prevalence, severity and risk factors
Gazzard et al.
Br. J. Ophthalmol. 2002;86:1341-1346.
ABSTRACT | FULL TEXT  

Overexpression of Collagenase (MMP-1) and Stromelysin (MMP-3) by Pterygium Head Fibroblasts
Li et al.
Arch Ophthalmol 2001;119:71-80.
ABSTRACT | FULL TEXT  

Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment
Ma et al.
Br. J. Ophthalmol. 2000;84:973-978.
ABSTRACT | FULL TEXT  

Regulation of Collagenase, Stromelysin, and Urokinase-Type Plasminogen Activator in Primary Pterygium Body Fibroblasts by Inflammatory Cytokines
Solomon et al.
IOVS 2000;41:2154-2163.
ABSTRACT | FULL TEXT  

Flow Cytometry Measurements of DNA Content in Primary and Recurrent Pterygia
Tan et al.
IOVS 2000;41:1684-1686.
ABSTRACT | FULL TEXT  

Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium
Ti et al.
Br. J. Ophthalmol. 2000;84:385-389.
ABSTRACT | FULL TEXT  

Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium
Tan et al.
Br. J. Ophthalmol. 2000;84:212-216.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.